Clinical trial
Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at…
NCT00138970 · University of Oslo School of Pharmacy, Other · Completed
Key facts
| NCT number | NCT00138970 |
|---|---|
| Title | Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk |
| Official title | Randomised, Double-Arm, Controlled, Open-Label Study Comparing Calcineurin Inhibitor-Free Immunosuppression (Zenapax®, CellCept® and Prednisolone) and Cyclosporine A Based Immunosuppression (Sandimmun Neoral®, CellCept® and Prednisolone) on the Outcome of Renal Function and Acute Rejection in 0 DR… |
| Lead sponsor | University of Oslo School of Pharmacy, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Renal Transplant Recipients |
| Intervention type | Drug |
| Interventions | Zenapax®, CellCept® and prednisolone, Sandimmun Neoral® |
| Enrollment | 70 |
| Start date | Jan 1, 2002 |
| Completion | Feb 1, 2005 |
| First posted | Aug 30, 2005 |
| Last update posted | Dec 1, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: